Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - ATX TR at 7871.14 - Addiko Bank, AT&S and Marinomed Biotech best-performing (30/03/2024)

31.03.2024

Finally a good Q1 ending for ATX which went up 1,85 percent and is now at 2,94 percent year to date. Best Stock in ATX was Bawag, even better performed S Immo and Addiko Bank in ATX Prime. News in Week 13 came from S Immo, Marinomed, Strabag, Pierer Mobility, FACC, Immofinanz, Frequentis and Palfinger. A big thx to Palfinger, the Company presented "Austrian Stocks in English" for nearly 100 Episodes.

BSNgine weekly Spitout: The ATX TR up 1,85% to 7.871,14 points this week. Year-to-date the ATX TR is now at 3,35%. Up to now there were 36 days with a positive and 27 with a negative gain. From the year-high we are 0% away, from the low 6,7%. Statistically the best weekday so far 2024 is Friday with 0,17%, the weakest is Wednesday with -0,03%.

These are the best-performers this week: Addiko Bank 16,18% in front of AT&S 14,5% and Marinomed Biotech 9,5%. And the following stocks performed worst: Strabag -11,75% in front of Andritz -3,91% and Immofinanz -3,62%.

Further highlights this week: S Immo for 9 days in a row up (12,09% gain from 15,72 to 17,62), also AT&S 7 days up (17,99% gain from 16,4 to 19,35), RBI 5 days up (3,88% gain from 17,77 to 18,46), FACC 3 days up (8,9% gain from 5,84 to 6,36), Marinomed Biotech 3 days up (11,17% gain from 19,7 to 21,9), Erste Group 3 days up (3,04% gain from 40,08 to 41,3), Polytec Group 3 days up (1,52% gain from 3,3 to 3,35).

Best-performers year-to-date as of now: S Immo 40,96% (last year: 0,16 percent) followed by Addiko Bank 34,46% (last year: 5,53 percent) and Bawag 22,34% (last year: -3,65 percent). And the worst-performing stocks year-to-date: AT&S -26,43% (Vorjahr: -17,81 percent), followed by Marinomed Biotech -25% (Vorjahr: -48,23 percent) and Verbund -19,39% (Vorjahr: 6,87 percent).

High above the MA200: Addiko Bank 32,84%, S Immo 32,48% and Bawag 26,66%.
Down under the MA200: Marinomed Biotech -36,73%, AT&S -26,49% and Semperit -25,69%.

 

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/03/2024)


Partners









latest 21st Austria

21st Austria weekly - ATX TR at 7871.14 - Addiko Bank, AT&S and Marinomed Biotech best-performing (30/03/2024)


31.03.2024, 2004 Zeichen



Finally a good Q1 ending for ATX which went up 1,85 percent and is now at 2,94 percent year to date. Best Stock in ATX was Bawag, even better performed S Immo and Addiko Bank in ATX Prime. News in Week 13 came from S Immo, Marinomed, Strabag, Pierer Mobility, FACC, Immofinanz, Frequentis and Palfinger. A big thx to Palfinger, the Company presented "Austrian Stocks in English" for nearly 100 Episodes.

BSNgine weekly Spitout: The ATX TR up 1,85% to 7.871,14 points this week. Year-to-date the ATX TR is now at 3,35%. Up to now there were 36 days with a positive and 27 with a negative gain. From the year-high we are 0% away, from the low 6,7%. Statistically the best weekday so far 2024 is Friday with 0,17%, the weakest is Wednesday with -0,03%.

These are the best-performers this week: Addiko Bank 16,18% in front of AT&S 14,5% and Marinomed Biotech 9,5%. And the following stocks performed worst: Strabag -11,75% in front of Andritz -3,91% and Immofinanz -3,62%.

Further highlights this week: S Immo for 9 days in a row up (12,09% gain from 15,72 to 17,62), also AT&S 7 days up (17,99% gain from 16,4 to 19,35), RBI 5 days up (3,88% gain from 17,77 to 18,46), FACC 3 days up (8,9% gain from 5,84 to 6,36), Marinomed Biotech 3 days up (11,17% gain from 19,7 to 21,9), Erste Group 3 days up (3,04% gain from 40,08 to 41,3), Polytec Group 3 days up (1,52% gain from 3,3 to 3,35).

Best-performers year-to-date as of now: S Immo 40,96% (last year: 0,16 percent) followed by Addiko Bank 34,46% (last year: 5,53 percent) and Bawag 22,34% (last year: -3,65 percent). And the worst-performing stocks year-to-date: AT&S -26,43% (Vorjahr: -17,81 percent), followed by Marinomed Biotech -25% (Vorjahr: -48,23 percent) and Verbund -19,39% (Vorjahr: 6,87 percent).

High above the MA200: Addiko Bank 32,84%, S Immo 32,48% and Bawag 26,66%.
Down under the MA200: Marinomed Biotech -36,73%, AT&S -26,49% and Semperit -25,69%.

 

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/03/2024)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #629: Wienerberger 155, B&C überlegt Changes bei Amag, Lenzing und Semperit, Fonds selbstbewusst vs. ETFs




 

Bildnachweis

Aktien auf dem Radar:Rosenbauer, Frequentis, SBO, Austriacard Holdings AG, Addiko Bank, RHI Magnesita, EVN, VIG, Wienerberger, Pierer Mobility, Bawag, UBM, SW Umwelttechnik, Oberbank AG Stamm, Agrana, Amag, CA Immo, Erste Group, Flughafen Wien, Immofinanz, Kapsch TrafficCom, Palfinger, Österreichische Post, Telekom Austria, Uniqa, Covestro, Deutsche Telekom, Intel, JP Morgan Chase, Deutsche Boerse, Beiersdorf.


Random Partner

Croma
Croma Pharma® ist ein österreichisches Familienunternehmen mit Sitz in Leobendorf. Das Unternehmen ist auf die industrielle Fertigung von Hyaluronsäure-Spritzen spezialisiert und zählt in diesem Bereich europaweit zu den führenden Experten. Das Unternehmen setzt mit eigenen Marken auf die Wachstumssparte der minimalinvasiven ästhetischen Medizin.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten